1-6 of 6
Todd E. DeFor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

Phuong Vo, Ted A. Gooley, Paul A. Carpenter, Mohamed L. Sorror, Margaret L. MacMillan, Todd E. DeFor, Paul J. Martin
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3220–3229.
https://doi.org/10.1182/bloodadvances.2021006220
Published: 2022
Journal Articles

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Clinical Trials & Observations
Margaret L. MacMillan, Keli L. Hippen, David H. McKenna, Diane Kadidlo, Darin Sumstad, Todd E. DeFor, Claudio G. Brunstein, Shernan G. Holtan, Jeffrey S. Miller, Erica D. Warlick, Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1425–1436.
https://doi.org/10.1182/bloodadvances.2020003219
Published: 2021
Includes: Supplemental data
Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Clinical Trials & Observations
Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1352–1359.
https://doi.org/10.1182/bloodadvances.2020003937
Published: 2021
Includes: Supplemental data
Journal Articles

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality

Clinical Trials & Observations
Celalettin Ustun, Todd E. DeFor, Fatma K. Karadag, Hyun Don Yun, Sunita Nathan, Claudio G. Brunstein, Bruce R. Blazar, Daniel J. Weisdorf, Shernan G. Holtan, Khalid Amin
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2317–2324.
https://doi.org/10.1182/bloodadvances.2020001793
Published: 2020
Journal Articles

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Clinical Trials & Observations
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1970–1980.
https://doi.org/10.1182/bloodadvances.2018028332
Published: 2019
Includes: Supplemental data
Journal Articles

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

Clinical Trials & Observations
Shernan G. Holtan, Todd E. DeFor, Angela Panoskaltsis-Mortari, Nandita Khera, John E. Levine, Mary E. D. Flowers, Stephanie J. Lee, Yoshihiro Inamoto, George L. Chen, Sebastian Mayer, Mukta Arora, Jeanne Palmer, Corey S. Cutler, Sally Arai, Aleksandr Lazaryan, Laura F. Newell, Madan H. Jagasia, Iskra Pusic, William A. Wood, Anne S. Renteria, Gregory Yanik, William J. Hogan, Elizabeth Hexner, Francis Ayuk, Ernst Holler, Udomsak Bunworasate, Yvonne A. Efebera, James L. M. Ferrara, Joseph Pidala, Alan Howard, Juan Wu, Javier Bolaños-Meade, Vincent Ho, Amin Alousi, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1882–1888.
https://doi.org/10.1182/bloodadvances.2018017343
Published: 2018
Includes: Supplemental data